INSM Trial readout: Thursday, November 5, 2026
CompanyInsmed Incorporated (INSM)
EventTrial readout
DateThursday, November 5, 2026
MarketUS listing
SourceEU CTIS registry · confidence 85% · primary source ↗
2026-526670-16-00 · Phase I · estimatedEndDate=2026-11-05 · Drug-drug interaction study of midazolam and brensocatib
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.